Acura Pharmaceuticals, Inc. (ACUR)
OTCMKTS
· Delayed Price · Currency is USD
0.0050
+0.0045 (900.00%)
Aug 14, 2025, 12:33 PM EDT
Acura Pharmaceuticals Revenue
In the year 2021, Acura Pharmaceuticals had annual revenue of $1.56M, down -56.22%. Acura Pharmaceuticals had revenue of $36.00K in the quarter ending December 31, 2021, a decrease of -94.99%.
Revenue
1.56M
Revenue Growth
-56.22%
P/S Ratio
0.21
Revenue / Employee
173.67K
Employees
9
Market Cap
332.50K
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2021 | 1.56M | -2.01M | -56.22% |
Dec 31, 2020 | 3.57M | 913.00K | 34.36% |
Dec 31, 2019 | 2.66M | 2.25M | 548.05% |
Dec 31, 2018 | 410.00K | -2.56M | -86.18% |
Dec 31, 2017 | 2.97M | -1.50M | -33.56% |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Dec 31, 2013 | Pro | Pro | Pro |
Dec 31, 2012 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 221.55M |
Elite Pharmaceuticals | 84.04M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.17M |
BioStem Technologies | 332.45M |
Acura Pharmaceuticals News
- 3 years ago - Acura Pharmaceuticals and AD Pharma Amend License to LIMITx™ LTX-03 - GlobeNewsWire
- 3 years ago - Acura Pharmaceuticals Provides Development Update on LTX-03 - GlobeNewsWire
- 4 years ago - Acura Pharmaceuticals Announces Third Quarter 2021 Financial Results - GlobeNewsWire
- 4 years ago - Acura Pharmaceuticals Announces Second Quarter 2021 Financial Results - GlobeNewsWire